Drug Trial Radar · NCT04412668
Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19
Last checked: Nov 19, 2026Latest source record: Aug 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
36
Actual
Start
Jun 4, 2020
Primary completion
Oct 23, 2020
Study completion Oct 23, 2020
Sponsor
- Lead sponsor
- aTyr Pharma, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 2, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and preliminary efficacy of efzofitimod, compared to placebo matched to efzofitimod, in hospitalized participants with SARS-CoV-2 (COVID-19) severe pneumonia not requiring mechanical ventilation.
Conditions
- SARS-CoV-2 (COVID-19) Severe Pneumonia
Interventions
Efzofitimod 1 mg/kgDrug
Concentrate for solution for infusion
Efzofitimod 3 mg/kgDrug
Concentrate for solution for infusion
PlaceboDrug
Concentrate for solution for infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)Time frame: Baseline up to Day 60
Locations
10 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
aTyr Investigative Site
Washington D.C., District of Columbia
University of Miami
Miami, Florida
University of Iowa
Iowa City, Iowa
Anne Arundel Medical Center
Annapolis, Maryland
aTyr Investigative Site
Vineland, New Jersey
aTyr Investigative Site
Toledo, Ohio
Inova Fairfax Medical Campus
Falls Church, Virginia
Alliance Medical Service, Cardio Pulmonary Research
Guaynabo, Puerto Rico
Manati Medical Center
Manati, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.